Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

Researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and collaborating institutions reveal ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Melanoma, the most dangerous form of skin cancer, often hides in plain sight. While many are vigilant about obvious changes ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

DNA fragments found in the bloodstream during treatment could mean that a patient’s cancer is getting worse, researchers said ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.